CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)
NCT02274584
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Lymphomas
Interventions
GENETIC:
Anti-CD30 CAR T cells
Sponsor
Peking University
Collaborators
[object Object]